article thumbnail

Cannabinoids, Influenza, and Coronavirus

Americans for Safe Access

With everything happening in the news lately, we want to present some scientific data to help medical cannabis patients and adult-use consumers make informed decisions in regard to cannabis products available, product safety, and personal health.

article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Additional information regarding cannabinoids and pain appears online h ere.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA Releases Plan To Obtain Data Regarding Cannabis-Derived Product Usage & Safety

Cannabis Law Report

Earlier this month, the FDA released a seven-page plan to accelerate its research into the safety of cannabis-derived products. Piloting market surveillance tools to monitor unapproved cannabis-derived products and “identify potential safety issues before the issues become mainstream.”

Safety 52
article thumbnail

Report: Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis

Cannabis Law Report

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events.

Safety 52
article thumbnail

NCIA Event, June 13: Paul Coble Moderates Panel on Testing and Labeling for “Minor Cannabinoid” Products

Canna Law Blog

The event is titled, From Lab to Label: Safegaurding Consumers in the Cannabinoid Product Landscape. This is the third webinar in the NCIA’s 5-part series on minor, novel, and synthetic cannabinoids like CBG, CBN, THCv, and many others.

Events 73
article thumbnail

Cannabinoids May Promote a Good Night’s Sleep, Study Finds

Veriheal

Published in the Journal of Medical Internet Research, the fresh data suggests that the cannabinoids found in cannabis, such as THC and CBD , may have potential as a treatment for sleep deprivation. Treating Insomnia With Cannabinoids.

Sleep 98
article thumbnail

Clinical Trial on Alzheimer’s Patients Indicates Positive Safety and Tolerability Data for IGC’s THC-Based Investigational New Drug

Cannabis Law Report

(“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. Safety and Tolerability (S&T) was assessed by asking participants to record Adverse Events (AEs).